Carlsmed (CARL) Asset Writedowns and Impairment (2024 - 2026)

Carlsmed (CARL) has reported Asset Writedowns and Impairment for 3 consecutive years, with $592000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Asset Writedowns and Impairment rose 5.53% year-over-year to $592000.0; the trailing twelve-month figure through Jun 2026 stood at $2.1 million (up 20.15% YoY), and the FY2025 full-year result was $1.8 million, up 33.45% from the prior year.
• Asset Writedowns and Impairment advanced to $592000.0 in Q2 2026 per CARL's latest filing, from $552000.0 in the prior quarter.
• Across five years, Asset Writedowns and Impairment topped out at $592000.0 in Q2 2026 and bottomed at $311000.0 in Q1 2025.
• Historically, Asset Writedowns and Impairment has averaged $483500.0 across 3 years, with a median of $499000.0 in 2024.
• The sharpest annual moves came in 2025 and 2026: Asset Writedowns and Impairment increased 1.21% in 2025, then jumped 77.49% in 2026.
• Over 3 years, Asset Writedowns and Impairment stood at $496000.0 in 2024, then climbed by 1.21% to $502000.0 in 2025, then rose by 17.93% to $592000.0 in 2026.
• According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $592000.0, $552000.0, and $502000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.